NRx Pharmaceuticals (NRXP) Institutional Ownership $1.32 -0.06 (-4.35%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$36.02MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$11.29M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2024AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010% 8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141% 2/14/2024AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% 1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022 United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, the following institutional investors and hedge funds held shares of NRx Pharmaceuticals shares: AdvisorShares Investments LLC ($279K), Sabby Management LLC ($84K), HBK Sorce Advisory LLC ($65K), One Wealth Management Investment & Advisory Services LLC ($37K), AE Wealth Management LLC ($33K), and Virtu Financial LLC ($30K), and Exchange Traded Concepts LLC ($30K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? The following institutional investors have purchased NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($642.63K), One Wealth Management Investment & Advisory Services LLC ($140.40K), HBK Sorce Advisory LLC ($58.46K), Virtu Financial LLC ($46.21K), Exchange Traded Concepts LLC ($32.64K), and AE Wealth Management LLC ($29.52K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 949,863 shares in the last 24 months. This purchase volume represents approximately $52.45M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($506.71K), Sabby Management LLC ($374.73K), and One Wealth Management Investment & Advisory Services LLC ($125.36K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 1,006,800 shares in the last 24 months. This volume of shares sold represents approximately $11.29M in transactions. Related Companies Momentus Major Shareholders Hall of Fame Resort & Entertainment Major Shareholders SCYNEXIS Major Shareholders OncoCyte Major Shareholders Affimed Major Shareholders Quince Therapeutics Major Shareholders Vor Biopharma Major Shareholders Anebulo Pharmaceuticals Major Shareholders Aadi Bioscience Major Shareholders Equillium Major Shareholders This page (NASDAQ:NRXP) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.